FDA-NIH Research Portfolio
This list contains grants and contracts carried over from prior fiscal years and new projects awarded in the current fiscal year for Special Research Priority on U.S. Food and Drug Administration (FDA) Tobacco Product Regulation.
Investigator Initiated, FY12
Program Projects Administrative Supplements, FY12
R01 Competitive Revisions, PAR-12-010, FY12
U01 Competitive Revisions, PAR-12-011, FY12
Communication Administrative Supplements, FY12
Administrative Supplements, NOT-CA-10-007, FY10
Contracts supported by FDA Center for Tobacco Products
Investigator Initiated for Special Research Priority on U.S Food and Drug Administration (FDA) Tobacco Product Regulation funded in fiscal year 2012.
Principal Investigator Organization |
Title |
Grant Number |
Blalock, J. Edwin University of Alabama at Birmingham |
PGP, A Possible Biomarker for COPD Exacerbations and or Progression |
1R01HL114439-01 |
Clark, Pamela I. University of Maryland College Park Campus |
Rapid response human testing of smokeless tobacco products |
1R01DA031142-01A1 |
Crystal, Ronald G Weill Medical College of Cornell University |
COPD Metabolome, Smoking Oxidants and Aberrant Ciliated Cell Function |
1P20HL113443-01 |
Cummings, K. Michael Medical University of South Carolina |
Effectiveness of tobacco control policies in high vs. low income countries |
3P01CA138389-05S1
(Admin Supplement) |
Delnevo, Cristine D. University of Medicine and Dentistry of New Jersey School of Public Health |
Measurement of Tobacco Use among South Asians in the U.S |
1R21CA164913-01A1 |
Donny, Eric Christian University of Pittsburgh at Pittsburgh |
Evaluating New Nicotine Standards for Cigarettes |
5U54DA031659-02 |
Gordon, Sydney Michael Battelle Centers/Public Health Research and Evaluation |
Real-Time Measurement and Uptake of Carcinogens by Menthol Cigarette Smokers |
5R01CA162085-02 |
Hatsukami, Dorothy K. University of Minnesota Twin Cities |
Models For Tobacco Product Evaluation |
1U19CA157345-01A1 |
Mays, Darren M. Georgetown University |
Framing Messages for Teen Smoking Prevention in Primary Care |
1R03CA162839-01A1 |
Nasim, Aashir Virginia Commonwealth University |
Cigarillo smoking: smoke toxicant content and user toxicant exposure and effects |
R21CA161317-01A1 |
Pickworth, Wallace Bruce Battelle Centers/Public Health Research and Evaluation |
Mainstream Smoke Composition and Toxin Exposure from Prototypical Cigar Products |
1R01CA158045-01A1 |
Rice, Virginia Hill Wayne State University |
Health Effects of Adolescent Water Pipe Smoking with & without Cigarette Smoking |
1R15DA032822-01 |
Romer, Daniel University of Pennsylvania |
Communicating Smoking Risks Through Graphic Warning Labels |
1R01CA157824-01A1 |
Sterling, Kymberle L. Georgia State University |
Developing Measures of Little Cigar Use for Young Adults |
1R03CA159909-01A1 |
Timberlake, David University of California Irvine |
Should Smokeless Tobacco be Promoted as an Alternative for Smokers ? |
1R03DA027950-01A1 |
Trumbo, Craig W. Colorado State University Fort Collins |
Social Normative Conditions and the Diffusion of Electronic Nicotine Delivery Sys |
1R03DA033578-01 |
Van Der Vliet, Albert University of Vermont and State Agriculture College |
Cigarette Smoke-derived Electrophilic Aldehydes and Airway Inflammation |
1R01ES021476-01 |
Williams, Rebecca S. University of North Carolina Chapel Hill |
Evaluating the Impact of Federal Legislation on Internet Tobacco Sales |
1R01CA169189-01 |
Zou, Ming-Hui
University of Oklahoma Health Sciences Center |
AMPK as a redox sensor and modulator |
2R01HL089920-05 |
Back to Top
Program Projects Administrative Supplements for Special Research Priority on U.S Food and Drug Administration (FDA) Tobacco Product Regulation, NOT-CA-12-007, funded in fiscal year 2012.
The grant titles and research descriptions reflect the parent awards. We are in the process of updating this content with the tobacco regulatory research being conducted through the administrative supplement.
Principal Investigator Organization |
Title |
Grant Number |
Carroll, Kathleen Yale University |
Psychotherapy Development Research Center |
3P50DA009241-19S1 |
Fiore, Michael & Baker, Tim University of Wisconsin |
Engineering Effective Interventions for Tobacco Use |
3P50CA143188-14S1 |
Guydish, Joseph
University of California San Francisco |
Treatment for Complex Patients: Continuing and Extended Care |
3P50DA009253-18S1 |
Malhotra, Anil
Feinsein Institute for Medical Research |
Dissecting Heterogeneity of Treatment Response of First Episode Schizophrenia |
3P50MH080173-05S2 |
Mermelstein, Robin University of Illinois and Chicago |
Social-Emotional Contexts of Adolescent Smoking Patterns |
3P01CA098262-08S1 |
Murry, Charles University of Washington |
Stem Cells and Cardiovascular Repair |
3P01HL094374-03S1 |
Ziegler, Steven Benaroya Institute |
Regulation of pulmonary inflammation by leukocytes and extracellular matrix |
3P01HL098067-03S1 |
Back to Top
R01 Competitive Revisions for Special Research Priority on U.S Food and Drug Administration (FDA) Tobacco Product Regulation, PAR-12-010, funded in fiscal year 2012.
The grant titles and research descriptions reflect the parent awards. We are in the process of updating this content with the tobacco regulatory research being conducted through the competitive revision.
Principal Investigator
Organization |
Title |
Grant Number |
Andrews, Judy A Oregon Research Institute |
Childhood and Adolescent Predictors of Substance Abuse in Emerging Adulthood |
3R01DA010767-14S2 |
Chassin, Laurie Arizona State University Tempe Campus |
Teen & Adult Smoking: Intergenerational Transmission and Prevention Applications |
3R01DA13555-30S1 |
Crystal, Ronald G. Weill Medical College of Cornell University |
Overlapping Airway Basal Cell Transcriptome Reprogramming in COPD and Lung Cancer |
3R01HL107882-2S1 |
Ding, Xinxin Wadsworth Center |
Human CYP2A and respiratory tract xenobiotic toxicity |
3R01CA92596-9S1 |
Haddock, Christopher Keith National Development and Research Institutes |
Barriers to Effective Tobacco Control Policy Implementation in the US Military |
3R01CA109153-7S1 |
Hecht, Stephen S. University of Minnesota Twin Cities |
Metabolism of Carcinogenic Tobacco-Specific Nitrosamines |
3R37CA81301-14S1 |
Jordt, Sven-Eric Yale University |
Counter-irritation by Menthol: Molecular Targets and Role in Airway Disease |
3R01HL105635-02S1 |
Klesges, Robert C. University of Tennessee Health Science Center |
Predictors of Smokeless Tobacco and Dual Use in the US Military |
3R01CA141567-4S1 |
Latkin, Carl A. Johns Hopkins University |
A comprehensive approach to secondary HIV prevention and care among positives |
3R01DA32217-2S1 |
Turesky, Robert J. Wadsworth Center |
2-Amino-9H-pyrido[2,3-b]indole: a potential colorectal carcinogen formed in tobacco |
3R01CA134700-3S1 |
Wewers, Mary Ellen Ohio State University |
Tobacco cessation interventions with Ohio Appalachian smokers |
3R01CA129771-03S1 |
Wolfson, Mark Wake Forest University Health Sciences |
Smokeless Tobacco Use in College Students |
3R01CA141643-4S2 |
Back to Top
U01 Competitive Revisions for Special Research Priority on U.S Food and Drug Administration (FDA) Tobacco Product Regulation, PAR-12-011, funded in fiscal year 2012.
The grant titles and research descriptions reflect the parent awards. We are in the process of updating this content with the tobacco regulatory research being conducted through the competitive revision.
Principal Investigator
Organization |
Title |
Grant Number |
Bailey, William C. University of Alabama at Birmingham |
Who and Why cigarette smokers use e-cigarettes after hospitalization |
3U01DA31515-3S1 |
Dubinett, Steven M. University of California Los Angeles |
The UCLA - Boston University Lung Cancer Biomarker Development Laboratory |
3U01CA152751-3S1 |
Lerman, Caryn University of Pennsylvania |
Pharmacogenetics of Nicotine Addiction Treatment |
3U01DA20830-8S1 |
Back to Top
Communication Administrative Supplements for Special Research Priority on U.S. Food and Drug Administration (FDA) Tobacco Product Regulation funded in fiscal year 2012.
We are in the process of updating the content with the tobacco regulatory research being conducted through the administrative supplement.
Principal Investigator
Organization |
Title |
Grant Number |
Hornik, Robert University of Pennsylvania |
Supporting the diffusion of the tobacco graphic warning labels |
3P20CA095856-09S1 |
Kreuter, Matthew W. Washington University in St. Louis |
Understanding reactions to graphic warning labels on cigarettes in diverse populations of youth and young adults at increased risk of smoking |
3P50CA095815-09S1 |
Williams, David R. Harvard University |
Assessing and Magnifying the Impact of Cigarette Pack Health Warnings among Vulnerable Populations: An Integrated Study |
3P50CA148596-03S1 |
Back to Top
Administrative Supplements for Special Research Priority on U.S. Food and Drug Administration (FDA) Tobacco Product Regulation, NOT-CA-10-007, funded in fiscal year 2010.
The grant titles and research descriptions reflect the parent awards. We are in the process of updating this content with the tobacco regulatory research being conducted through the administrative supplement.
Principal Investigator
Organization |
Title |
Grant Number |
Connolly, Gregory N. Harvard School of Public Health |
Subjective and Behavioral Responses to PREP Design and Marketing: Modification of risk perceptions of light cigarettes |
3R01CA125224-03S1 |
Cummings, K. Michael Roswell Park Cancer Institute |
Effectiveness of Tobacco Control Policies in High vs. Low Income Countries |
3P01CA138389-02S |
Fong, Geoffrey T. University of Waterloo |
International Tobacco Policy Surveys |
3R01CA100362-05S1 |
Forster, Jean University of Minnesota |
The Effects of Minnesota State and Local Programs on Young Adult Tobacco Use |
3R01CA086191-10A1S1 |
Hatsukami, Dorothy K. University of Minnesota |
Novel Determinants of Measures of Smokeless Tobacco Use |
3R01CA141531-02S1 |
Henriksen, Lisa A. Stanford University |
Impact of Retail Tobacco Advertising on Youth Smoking |
3R01CA067850-10A1S1 |
Ling, Pamela M.
University of California San Francisco |
Understanding Smokeless Tobacco Marketing |
3R01CA141661-02S1 |
Strasser, Andrew A.
Stanford University |
Smoking Topography and Harm Exposure in a New PREP |
3R01CA120594-04S1 |
Back to Top
These contracts are also supported by the FDA CTP.
Population Assessment of Tobacco and Health (PATH) Study
In October 2011, the Food and Drug Administration (FDA) and the National Institutes of Health (NIH) announced a joint national, prospective, longitudinal cohort study of tobacco users and those at risk for tobacco-product use to monitor and assess their tobacco use and the resultant health impacts. The initiative, called the Population Assessment of Tobacco and Health (PATH) Study, represents the first large-scale NIH-FDA collaboration on tobacco regulatory research since Congress granted FDA the authority to regulate tobacco products under the Family Smoking Protection and Tobacco Control Act (FSPTCA). Scientific experts at the National Institute on Drug Abuse (NIDA) and FDA’s Center for Tobacco Products (CTP) will coordinate this effort via a research contract awarded to Westat in Rockville, MD.
The PATH Study will prospectively follow almost 60,000 people who are users of tobacco products and those at risk for tobacco-product use ages 12 and older in the United States. The study will a) examine what makes people susceptible to tobacco-product use; b) evaluate initiation and use patterns including use of new products, dual use, poly use, and switching of tobacco products; c) study patterns of tobacco-product cessation and relapse ; d) evaluate the effects of regulatory changes on risk perceptions and other tobacco-related attitudes; and e) assess differences in attitudes, behaviors, and key health outcomes among racial/ethnic, gender, and age subgroups. The PATH Study will also collect biospecimens from adults to analyze biomarkers of tobacco use and disease processes.
By measuring and accurately reporting on the social, behavioral and health effects associated with tobacco-product use in the U.S., the PATH Study will provide an empirical evidence base to inform the development and assessment of tobacco-product regulations by the FDA.
Other NIH Tobacco-Related Research
NIH funds other tobacco-related research. For a complete portfolio of NIH-supported tobacco research visit the NIH Research Portfolio Online Reporting Tools Expenditures and Results (NIH RePORT) or use the widget below. |
|
Back to Top